By the Editorial Board
The Ministry of Health’s directive of April 3, 2026, is not unreasonable on its face. Requiring a valid prescription from a licensed physician for Misoprostol, and mandating its use under the supervision of a licensed pharmacist within an approved facility, sounds like sensible regulation. The stated goal—curbing widespread unregulated sale and misuse—is legitimate.
But we are deeply concerned that well-intentioned enforcement, applied without nuance and without parallel investment in access, will produce the opposite of its stated aim. Instead of saving lives, overly restrictive implementation could cost them. And in a country with Liberia’s maternal mortality record, that is not a risk the government can afford to take.
Liberia has one of the highest maternal mortality ratios in the world: an estimated 742 deaths per 100,000 live births. Unsafe abortion and related complications contribute substantially to these deaths. This is not a abstract statistic. It is Liberian women. It is Liberian daughters. It is preventable death.
Misoprostol is not a recreational drug. It is an essential medicine recognized by the World Health Organization. It prevents postpartum hemorrhage. It manages miscarriages safely. It can be used alongside other medicines in medical abortion. In short, it saves lives—when women can get it.
The Ministry of Health is collaborating with the Liberia Medicines and Health Products Regulatory Authority, the Liberia Pharmacy Board, and the Liberia Medical & Dental Council to strengthen supply chain monitoring, inspect pharmaceutical outlets, verify registration records, and crack down on fraudulent prescriptions and illegal distribution. All of that is commendable. All of that should continue.
But here is the question the Ministry has not answered: What happens to the woman in a rural village with no physician within a day’s travel? What happens to the adolescent survivor of sexual violence who cannot access an approved facility? What happens to the low-income mother who cannot afford a private doctor’s prescription? The answer, as women’s rights groups have pointed out, is that she will not simply accept her fate. She will turn to clandestine providers, dangerous traditional methods, or self-induced procedures. And too often, she will die.
The Women NGOs Secretariat of Liberia (WONGOSOL), representing more than 250 women-led organizations, has warned that overly restrictive implementation could deepen Liberia’s maternal mortality crisis. That warning deserves to be taken seriously, not dismissed as advocacy overreach. These are the organizations working on the front lines. They see what happens when access is blocked.
Similarly, prominent feminist and human rights activist Naomi Tulay Solanke stated plainly on social media: “Misoprostol is not a luxury. It is an essential medicine… It saves lives.” She also noted that the burden of restricted access falls most heavily on low-income women, girls, rural communities, adolescents, survivors of sexual violence, and people living far from clinics. She is correct.
To be clear, this paper is not arguing against all regulation. The Ministry’s concern about unregulated sale and misuse is valid. The directive’s enforcement mechanisms—inspections, record verification, credential checks, criminal action against illegal distribution—are appropriate tools. But regulation without access is not public health policy. It is a barrier. And barriers do not stop abortions. They stop safe abortions.
Liberia’s abortion law, dating to 1976, permits abortion only up to 24 weeks and only in cases of rape, fetal impairment, or risk to the mother’s physical or mental health or life. A bill to legalize abortion, introduced in 2020, remains under debate as of 2026. While that political debate continues, women are dying. The Misoprostol directive must not add to that toll.
The Ministry has said it will assist in investigations of illegal distribution and support criminal action where warranted. That is appropriate. But criminalizing access is not the same as criminalizing abuse. The government must not confuse the two. Access to health care is a fundamental human right. It is grounded in Liberia’s Constitution and reinforced by international and regional commitments, including the Convention on the Elimination of All Forms of Discrimination Against Women, the African Charter on Human and Peoples’ Rights, and the Maputo Protocol. These are not optional aspirations. They are binding obligations.
The Ministry of Health has the authority to regulate. It does not have the moral license to block access under the guise of control. Regulate wisely. Enforce fairly. But do not become another reason Liberian women die.
